171 related articles for article (PubMed ID: 25266282)
21. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
[TBL] [Abstract][Full Text] [Related]
22. Controlling degradation of acid-hydrolyzable pluronic hydrogels by physical entrapment of poly(lactic acid-co-glycolic acid) microspheres.
Lee JB; Chun KW; Yoon JJ; Park TG
Macromol Biosci; 2004 Oct; 4(10):957-62. PubMed ID: 15487026
[TBL] [Abstract][Full Text] [Related]
23. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
24. Modification of the release characteristics of estradiol encapsulated in PLGA particles via surface coating.
Enayati M; Stride E; Edirisinghe M; Bonfield W
Ther Deliv; 2012 Feb; 3(2):209-26. PubMed ID: 22834198
[TBL] [Abstract][Full Text] [Related]
25. Preparation of sustained release microparticles with improved initial release property.
Jung GY; Na YE; Park MS; Park CS; Myung PK
Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
27. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
[TBL] [Abstract][Full Text] [Related]
28. Characterization of PLGA microparticles as a drug carrier for 3-ethoxycarbonyl-2h-benzofuro[3,2-f]-1-benzopyran-2-one. Ultrastructural study of cellular uptake and intracellular distribution.
Gomes AJ; Faustino AS; Machado AE; Zaniquelli ME; de Paula Rigoletto T; Lunardi CN; Lunardi LO
Drug Deliv; 2006; 13(6):447-54. PubMed ID: 17002973
[TBL] [Abstract][Full Text] [Related]
29. Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases.
Rassu G; Salis A; Porcu EP; Giunchedi P; Roldo M; Gavini E
Carbohydr Polym; 2016 Jan; 136():1338-47. PubMed ID: 26572479
[TBL] [Abstract][Full Text] [Related]
30. Microspheres prepared with different co-polymers of poly(lactic-glycolic acid) (PLGA) or with chitosan cause distinct effects on macrophages.
Bitencourt Cda S; Silva LB; Pereira PA; Gelfuso GM; Faccioli LH
Colloids Surf B Biointerfaces; 2015 Dec; 136():678-86. PubMed ID: 26497115
[TBL] [Abstract][Full Text] [Related]
31. PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization.
Manca ML; Mourtas S; Dracopoulos V; Fadda AM; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Apr; 62(2):220-31. PubMed ID: 18023977
[TBL] [Abstract][Full Text] [Related]
32. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery.
Wang Y; Li P; Kong L
AAPS PharmSciTech; 2013 Jun; 14(2):585-92. PubMed ID: 23463262
[TBL] [Abstract][Full Text] [Related]
33. Controlling microencapsulation and release of micronized proteins using poly(ethylene glycol) and electrospraying.
Bock N; Dargaville TR; Woodruff MA
Eur J Pharm Biopharm; 2014 Jul; 87(2):366-77. PubMed ID: 24657821
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of P(L)LA-PEG-P(L)LA as processing aid for biodegradable particles from gas saturated solutions (PGSS) process.
Perinelli DR; Bonacucina G; Cespi M; Naylor A; Whitaker M; Palmieri GF; Giorgioni G; Casettari L
Int J Pharm; 2014 Jul; 468(1-2):250-7. PubMed ID: 24746690
[TBL] [Abstract][Full Text] [Related]
35. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
[TBL] [Abstract][Full Text] [Related]
36. Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.
Faisant N; Akiki J; Siepmann F; Benoit JP; Siepmann J
Int J Pharm; 2006 May; 314(2):189-97. PubMed ID: 16510257
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
38. Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights.
Hines DJ; Kaplan DL
Crit Rev Ther Drug Carrier Syst; 2013; 30(3):257-76. PubMed ID: 23614648
[TBL] [Abstract][Full Text] [Related]
39. Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.
Grabowski N; Hillaireau H; Vergnaud J; Tsapis N; Pallardy M; Kerdine-Römer S; Fattal E
Int J Pharm; 2015 Mar; 482(1-2):75-83. PubMed ID: 25448553
[TBL] [Abstract][Full Text] [Related]
40. A study of drug release from homogeneous PLGA microstructures.
Acharya G; Shin CS; Vedantham K; McDermott M; Rish T; Hansen K; Fu Y; Park K
J Control Release; 2010 Sep; 146(2):201-6. PubMed ID: 20381555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
